AVANOS MEDICAL
Acquired by
AMERICAN INDUSTRIAL PARTNERS AIP
AVANOS MEDICAL acquired by AMERICAN INDUSTRIAL PARTNERS AIP
Target
AVANOS MEDICAL
Acquirer
AMERICAN INDUSTRIAL PARTNERS AIP
Context
American Industrial Partners has finalized a definitive agreement to acquire Avanos Medical in an all-cash transaction, a maneuver designed to fundamentally reinforce the target's competitive positioning in the specialized medical technology arena. The strategic rationale for this transaction centers on an "operational-transformation" play, merging the target's industry-leading technical operational depth in nutrition and pain therapies with the acquirer's extensive history of implementing transformative operating agendas. This structural alignment provides the organization with the institutional capital and private-market flexibility required to pursue a definitive expansion of its innovation roadmap without the pressures of public-market cyclicality.
AVANOS MEDICAL, which reported an EBITDA margin of LOGIN in 2025, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN premium to the 13.4x average currently observed in the Healthcare & Pharma sector.
Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in Healthcare & Pharma market trends
Target
Avanos Medical operates as a premier technology organization dedicated to the engineering and distribution of clinically superior medical device solutions. The entity’s business model is centered on a high-fidelity diagnostic and therapeutic framework, specializing in the Specialty Nutrition Systems (SNS) and Pain Management and Recovery (PM&R) segments. Its value proposition is anchored in technical operational depth, providing mission-critical solutions such as enteral feeding tubes, neonatal feeding systems, and non-opioid surgical pain management therapies. Strategically, the firm focuses on the deployment of industrialized safety standards to reduce opioid dependency and facilitate the transition of patients from hospital to home care. By maintaining a specialized focus on technical reliability and life-sustaining nutrition delivery, the organization ensures a vital role in the structural advancement of post-operative and chronic patient care.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples Analysis
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (EUR)
Other operations with AVANOS MEDICAL
mynth data is contributed by M&A / PE professionals and systematically cross-verified against private deal documents and official releases. All source materials are destroyed post-validation to guarantee data anonymity and compliance.